Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A Prospective, Observational, Multicenter Study (ANTHICUS)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00543894

Acronym

ANTHICUS

Enrollment

500

Registered

2007-10-15

Start date

2006-02-28

Completion date

Unknown

Last updated

2008-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection in ICU

Keywords

Antibiotic, ICU, hospital acquired infection.

Brief summary

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Inclusion criteria

* Patients with hospital-acquired infections and hospitalised in the ICU at one moment of their hospital stay * Hospital-acquired infections accounting for eligibility are: * nosocomial pneumonia (including ventilator-associated pneumonia) * bacteremia * intra-abdominal infections * urosepsis

Design outcomes

Secondary

Measure	Time frame
the frequency of appropriate antibiotic therapy (defined as the use of antibiotic(s) with in vitro efficacy against the identified pathogens responsible for the infection)	—
the frequency of the strategy of de-escalation according to the culture results	—

Outcome results